Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT

Avichai Shimoni; Marie Robin; Simona Iacobelli; Dietrich Beelen; Ghulam J. Mufti; Fabio Ciceri; Wolfgang Bethge; Liisa Volin; Didier Blaise; Arnold Ganser; Thomas Luft; Patrice Chevallier; Rainer Schwerdtfeger; Linda Koster; Theo de Witte; Nicolaus Kroeger; Arnon Nagler; Ibrahim Yakoub-Agha

doi:10.1111/bjh.17817

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT

Avichai Shimoni, Marie Robin, Simona Iacobelli, Dietrich Beelen, Ghulam J. Mufti, Fabio Ciceri, Wolfgang Bethge, Liisa Volin, Didier Blaise, Arnold Ganser, Thomas Luft, Patrice Chevallier, Rainer Schwerdtfeger, Linda Koster, Theo de Witte, Nicolaus Kroeger, Arnon Nagler, Ibrahim Yakoub-Agha

HUS Cancercentrum

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	British Journal of Haematology
Volym	195
Nummer	3
Sidor (från-till)	417-428
Antal sidor	12
ISSN	0007-1048
DOI	https://doi.org/10.1111/bjh.17817
Status	Publicerad - nov. 2021
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3122 Cancersjukdomar

Åtkomst av dokument

10.1111/bjh.17817

Citera det här

Shimoni, A., Robin, M., Iacobelli, S., Beelen, D., Mufti, G. J., Ciceri, F., Bethge, W., Volin, L., Blaise, D., Ganser, A., Luft, T., Chevallier, P., Schwerdtfeger, R., Koster, L., de Witte, T., Kroeger, N., Nagler, A., & Yakoub-Agha, I. (2021). Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT. British Journal of Haematology, 195(3), 417-428. https://doi.org/10.1111/bjh.17817

Shimoni, Avichai ; Robin, Marie ; Iacobelli, Simona et al. / Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT. I: British Journal of Haematology. 2021 ; Vol. 195, Nr. 3. s. 417-428.

@article{4c76c912000349a9b0e00d98ec8c8170,

title = "Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT",

keywords = "myelodysplastic syndrome, allogeneic haematopoietic cell transplantation, reduced-intensity conditioning, myeloablative conditioning, treosulfan, ACUTE MYELOID-LEUKEMIA, VERSUS-HOST-DISEASE, PREPARATIVE REGIMEN, OPEN-LABEL, FLUDARABINE, MARROW, TOXICITY, BUSULFAN, GRAFT, MDS, 3122 Cancers",

author = "Avichai Shimoni and Marie Robin and Simona Iacobelli and Dietrich Beelen and Mufti, {Ghulam J.} and Fabio Ciceri and Wolfgang Bethge and Liisa Volin and Didier Blaise and Arnold Ganser and Thomas Luft and Patrice Chevallier and Rainer Schwerdtfeger and Linda Koster and {de Witte}, Theo and Nicolaus Kroeger and Arnon Nagler and Ibrahim Yakoub-Agha",

year = "2021",

month = nov,

doi = "10.1111/bjh.17817",

language = "English",

volume = "195",

pages = "417--428",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley",

number = "3",

}

Shimoni, A, Robin, M, Iacobelli, S, Beelen, D, Mufti, GJ, Ciceri, F, Bethge, W, Volin, L, Blaise, D, Ganser, A, Luft, T, Chevallier, P, Schwerdtfeger, R, Koster, L, de Witte, T, Kroeger, N, Nagler, A & Yakoub-Agha, I 2021, 'Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT', British Journal of Haematology, vol. 195, nr. 3, s. 417-428. https://doi.org/10.1111/bjh.17817

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT. / Shimoni, Avichai; Robin, Marie; Iacobelli, Simona et al.

I: British Journal of Haematology, Vol. 195, Nr. 3, 11.2021, s. 417-428.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

TY - JOUR

T1 - Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT

AU - Shimoni, Avichai

AU - Robin, Marie

AU - Iacobelli, Simona

AU - Beelen, Dietrich

AU - Mufti, Ghulam J.

AU - Ciceri, Fabio

AU - Bethge, Wolfgang

AU - Volin, Liisa

AU - Blaise, Didier

AU - Ganser, Arnold

AU - Luft, Thomas

AU - Chevallier, Patrice

AU - Schwerdtfeger, Rainer

AU - Koster, Linda

AU - de Witte, Theo

AU - Kroeger, Nicolaus

AU - Nagler, Arnon

AU - Yakoub-Agha, Ibrahim

PY - 2021/11

Y1 - 2021/11

KW - myelodysplastic syndrome

KW - allogeneic haematopoietic cell transplantation

KW - reduced-intensity conditioning

KW - myeloablative conditioning

KW - treosulfan

KW - ACUTE MYELOID-LEUKEMIA

KW - VERSUS-HOST-DISEASE

KW - PREPARATIVE REGIMEN

KW - OPEN-LABEL

KW - FLUDARABINE

KW - MARROW

KW - TOXICITY

KW - BUSULFAN

KW - GRAFT

KW - MDS

KW - 3122 Cancers

U2 - 10.1111/bjh.17817

DO - 10.1111/bjh.17817

M3 - Article

VL - 195

SP - 417

EP - 428

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 3

ER -

Shimoni A, Robin M, Iacobelli S, Beelen D, Mufti GJ, Ciceri F et al. Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT. British Journal of Haematology. 2021 nov.;195(3):417-428. Epub 2021 sep. 12. doi: 10.1111/bjh.17817